APA
Herishanu Y., Shaulov A., Fineman R., Bašić-Kinda S., Aviv A., Wasik-Szczepanek E., Jaksic O., Zdrenghea M., Greenbaum U., Mandac I., Simkovic M., Morawska M., Benjamini O., Spacek M., Nemets A., Bairey O., Trentin L., Ruchlemer R., Laurenti L., Stanca Ciocan O., Doubek M., Shvidel L., Dali N., Mirás F., De Meûter A., Dimou M., Mauro F. R., Coscia M., Bumbea H., Szász R., Tadmor T., Gutwein O., Gentile M., Scarfò L., Tedeschi A., Sportoletti P., Gimeno Vázquez E., Marquet J., Assouline S., Papaioannou M., Braester A., Levato L., Gregor M., Rigolin G. M., Loscertales J., Medina Perez A., Nijziel M. R., Popov V. M., Collado R., Slavutsky I., Itchaki G., Ringelstein S., Goldschmidt N., Perry C., Levi S., Polliack A. & Ghia P. (20200623). Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. : American journal of hematology.
Chicago
Herishanu Yair, Shaulov Adir, Fineman Riva, Bašić-Kinda Sandra, Aviv Ariel, Wasik-Szczepanek Ewa, Jaksic Ozren, Zdrenghea Mihnea, Greenbaum Uri, Mandac Inga, Simkovic Martin, Morawska Marta, Benjamini Ohad, Spacek Martin, Nemets Anatoly, Bairey Osnat, Trentin Livio, Ruchlemer Rosa, Laurenti Luca, Stanca Ciocan Oana, Doubek Michael, Shvidel Lev, Dali Nagib, Mirás Fátima, De Meûter Anne, Dimou Maria, Mauro Francesca R, Coscia Marta, Bumbea Horia, Szász Róbert, Tadmor Tamar, Gutwein Odit, Gentile Massimo, Scarfò Lydia, Tedeschi Alessandra, Sportoletti Paolo, Gimeno Vázquez Eva, Marquet Juan, Assouline Sarit, Papaioannou Maria, Braester Andrei, Levato Luciano, Gregor Michael, Rigolin Gian M, Loscertales Javier, Medina Perez Angeles, Nijziel Marten R, Popov Viola M, Collado Rosa, Slavutsky Irma, Itchaki Gilad, Ringelstein Shimrit, Goldschmidt Neta, Perry Chava, Levi Shai, Polliack Aaron and Ghia Paolo. 20200623. Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. : American journal of hematology.
Harvard
Herishanu Y., Shaulov A., Fineman R., Bašić-Kinda S., Aviv A., Wasik-Szczepanek E., Jaksic O., Zdrenghea M., Greenbaum U., Mandac I., Simkovic M., Morawska M., Benjamini O., Spacek M., Nemets A., Bairey O., Trentin L., Ruchlemer R., Laurenti L., Stanca Ciocan O., Doubek M., Shvidel L., Dali N., Mirás F., De Meûter A., Dimou M., Mauro F. R., Coscia M., Bumbea H., Szász R., Tadmor T., Gutwein O., Gentile M., Scarfò L., Tedeschi A., Sportoletti P., Gimeno Vázquez E., Marquet J., Assouline S., Papaioannou M., Braester A., Levato L., Gregor M., Rigolin G. M., Loscertales J., Medina Perez A., Nijziel M. R., Popov V. M., Collado R., Slavutsky I., Itchaki G., Ringelstein S., Goldschmidt N., Perry C., Levi S., Polliack A. and Ghia P. (20200623). Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. : American journal of hematology.
MLA
Herishanu Yair, Shaulov Adir, Fineman Riva, Bašić-Kinda Sandra, Aviv Ariel, Wasik-Szczepanek Ewa, Jaksic Ozren, Zdrenghea Mihnea, Greenbaum Uri, Mandac Inga, Simkovic Martin, Morawska Marta, Benjamini Ohad, Spacek Martin, Nemets Anatoly, Bairey Osnat, Trentin Livio, Ruchlemer Rosa, Laurenti Luca, Stanca Ciocan Oana, Doubek Michael, Shvidel Lev, Dali Nagib, Mirás Fátima, De Meûter Anne, Dimou Maria, Mauro Francesca R, Coscia Marta, Bumbea Horia, Szász Róbert, Tadmor Tamar, Gutwein Odit, Gentile Massimo, Scarfò Lydia, Tedeschi Alessandra, Sportoletti Paolo, Gimeno Vázquez Eva, Marquet Juan, Assouline Sarit, Papaioannou Maria, Braester Andrei, Levato Luciano, Gregor Michael, Rigolin Gian M, Loscertales Javier, Medina Perez Angeles, Nijziel Marten R, Popov Viola M, Collado Rosa, Slavutsky Irma, Itchaki Gilad, Ringelstein Shimrit, Goldschmidt Neta, Perry Chava, Levi Shai, Polliack Aaron and Ghia Paolo. Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. : American journal of hematology. 20200623.